These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32959708)

  • 1. Effects of cigarette smoking and human T-cell leukaemia virus type 1 infection on anti-citrullinated peptide antibody production in Japanese community-dwelling adults: the Nagasaki Islands Study.
    Kawashiri SY; Tsuji Y; Tamai M; Nonaka F; Nobusue K; Yamanashi H; Maeda T; Kawakami A
    Scand J Rheumatol; 2021 Jul; 50(4):295-298. PubMed ID: 32959708
    [No Abstract]   [Full Text] [Related]  

  • 2. Rate of positive autoimmune markers in Human T lymphotropic virus type 1 carriers: a case-control study from Iran.
    Ahmadi Ghezeldasht S; Hedayati-Moghaddam MR; Habibi M; Mollahosseini F; Rafatpanah H; Miri R; Hatef Fard M; Sahebari M
    Int J Rheum Dis; 2018 Jan; 21(1):108-113. PubMed ID: 28261958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Period prevalence of uveitis in human T-lymphotropic virus 1 carriers versus noncarriers in a highly endemic area: The Nagasaki Islands Study.
    Miyata J; Yamanashi H; Dake Y; Nobusue K; Doi Y; Honda Y; Nonaka F; Arima K; Tamai M; Sasaki D; Shimizu Y; Hasegawa H; Kitaoka T; Yanagihara K; Aoyagi K; Kawakami A; Maeda T
    J Med Virol; 2024 May; 96(5):e29653. PubMed ID: 38712746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term exposure to a mixture of industrial SO
    Zhao N; Smargiassi A; Hatzopoulou M; Colmegna I; Hudson M; Fritzler MJ; Awadalla P; Bernatsky S
    Environ Health; 2020 Jul; 19(1):86. PubMed ID: 32727483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief Report: Attenuated Effectiveness of Tumor Necrosis Factor Inhibitors for Anti-Human T Lymphotropic Virus Type I Antibody-Positive Rheumatoid Arthritis.
    Suzuki T; Fukui S; Umekita K; Miyamoto J; Umeda M; Nishino A; Okada A; Koga T; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Fujikawa K; Aramaki T; Mizokami A; Matsuoka N; Ueki Y; Eguchi K; Sato S; Hidaka T; Origuchi T; Okayama A; Kawakami A; Nakamura H
    Arthritis Rheumatol; 2018 Jul; 70(7):1014-1021. PubMed ID: 29471588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cumulative anti-cyclic citrullinated protein antibodies with radiographic progression in patients with rheumatoid arthritis.
    Joo YB; Park YJ; Park KS; Kim KJ
    Clin Rheumatol; 2019 Sep; 38(9):2423-2432. PubMed ID: 31049760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica.
    Birmann BM; Breen EC; Stuver S; Cranston B; Martínez-Maza O; Falk KI; Okayama A; Hanchard B; Mueller N; Hisada M
    Int J Cancer; 2009 Feb; 124(3):614-21. PubMed ID: 18989900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti -citrullinated peptide antibodies profiling in established rheumatoid arthritis.
    Manca ML; Alunno A; D'Amato C; Bistoni O; Puxeddu I; Gerli R; Migliorini P; Pratesi F
    Joint Bone Spine; 2018 Jul; 85(4):441-445. PubMed ID: 28826660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of human T-cell leukemia virus type 1 with prevalent rheumatoid arthritis among atomic bomb survivors: A cross-sectional study.
    Hida A; Imaizumi M; French B; Ohishi W; Haruta D; Eguchi K; Nakamura H; Kawakami A
    Medicine (Baltimore); 2021 Jun; 100(24):e26297. PubMed ID: 34128866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study.
    Boman A; Brink M; Lundquist A; Hansson M; Mathsson-Alm L; Rönnelid J; Berglin E; Holmdahl R; Skriner K; Serre G; Klareskog L; Rantapää-Dahlqvist S
    RMD Open; 2019; 5(2):e000946. PubMed ID: 31565241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking and susceptibility to rheumatoid arthritis in a Swedish population-based case-control study.
    Hedström AK; Stawiarz L; Klareskog L; Alfredsson L
    Eur J Epidemiol; 2018 Apr; 33(4):415-423. PubMed ID: 29387991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant association of periodontal disease with anti-citrullinated peptide antibody in a Japanese healthy population - The Nagahama study.
    Terao C; Asai K; Hashimoto M; Yamazaki T; Ohmura K; Yamaguchi A; Takahashi K; Takei N; Ishii T; Kawaguchi T; Tabara Y; Takahashi M; Nakayama T; Kosugi S; Sekine A; Fujii T; Yamada R; Mimori T; Matsuda F; Bessho K;
    J Autoimmun; 2015 May; 59():85-90. PubMed ID: 25819755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain.
    Eloff E; Martinsson K; Ziegelasch M; Cedergren J; Reckner Å; Skogh T; Karlsson L; Ärlemalm A; Borggreven NV; Trouw LA; Kastbom A
    Scand J Rheumatol; 2021 May; 50(3):189-197. PubMed ID: 33243072
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of Antibodies to Citrullinated Protein Antigens with Blood Pressure in First-Degree Relatives of Rheumatoid Arthritis Patients: The Studies of the Etiology of Rheumatoid Arthritis.
    Hughes-Austin JM; Gan RW; Deane KD; Weisman MH; Demoruelle MK; Sokolove J; Robinson WH; Holers VM; Norris JM; Ix JH
    Am J Nephrol; 2017; 46(6):481-487. PubMed ID: 29237149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.
    van Wesemael TJ; Ajeganova S; Humphreys J; Terao C; Muhammad A; Symmons DP; MacGregor AJ; Hafström I; Trouw LA; van der Helm-van Mil AH; Huizinga TW; Mimori T; Toes RE; Matsuda F; Svensson B; Verstappen SM; van der Woude D
    Arthritis Res Ther; 2016 Dec; 18(1):285. PubMed ID: 27906045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis.
    Ogawa Y; Takahashi N; Kaneko A; Hirano Y; Kanayama Y; Yabe Y; Oguchi T; Fujibayashi T; Takagi H; Hanabayashi M; Funahashi K; Hayashi M; Tsuboi S; Asai S; Asai N; Matsumoto T; Sobue Y; Ishiguro N; Kojima T
    Clin Rheumatol; 2019 Oct; 38(10):2757-2763. PubMed ID: 31179526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking is a risk factor for development of adult T-cell leukemia/lymphoma in Japanese human T-cell leukemia virus type-1 carriers.
    Kondo H; Soda M; Sawada N; Inoue M; Imaizumi Y; Miyazaki Y; Iwanaga M; Tanaka Y; Mizokami M; Tsugane S
    Cancer Causes Control; 2016 Sep; 27(9):1059-66. PubMed ID: 27412633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum rheumatoid factor, anti-citrullinated protein antibodies and active rheumatoid arthritis disease are not associated with chronic periodontitis.
    Che Rahim MJ; Wan Mohamad WM; Saddki N; Taib H; Wan Abhamid WZ; Wong KK; Wan Ghazali WS
    Malays J Pathol; 2019 Dec; 41(3):267-272. PubMed ID: 31901911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I.
    Hisada M; Okayama A; Shioiri S; Spiegelman DL; Stuver SO; Mueller NE
    Blood; 1998 Nov; 92(10):3557-61. PubMed ID: 9808547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T-cell lymphotropic virus type-1 infection associated with sarcopenia: community-based cross-sectional study in Goto, Japan.
    Yamanashi H; Nobusue K; Nonaka F; Honda Y; Shimizu Y; Kawashiri SY; Izumida M; Kubo Y; Tamai M; Nagata Y; Yanagihara K; Kulkarni B; Kinra S; Kawakami A; Maeda T
    Aging (Albany NY); 2020 Jul; 12(15):15504-15513. PubMed ID: 32706758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.